Bioskryb is a company bringing solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system. Its technology enables coverage of the entire genome during DNA amplification and allows for accuracy and uniformity in DNA sequence coverage and base calling – the identification of the individual DNA bases.
|Employees (est.) (Sept 2021)||31||(+4%)|
BioSkryb total Funding
BioSkryb latest funding size
Time since last funding
|2 years ago|
|Wilson Sonsini Goodrich & Rosati, Anzu Partners|
BioSkryb has 57 Twitter Followers. The number of followers has increased 1.8% month over month and increased 17.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was BioSkryb founded?
BioSkryb was founded in 2018.
Who are BioSkryb key executives?
BioSkryb's key executives are Jay West, Charles Gawad and Wendi Carter.
How many employees does BioSkryb have?
BioSkryb has 31 employees.
Who are BioSkryb competitors?
Competitors of BioSkryb include Crioestaminal, ProteinSimple and Jackson ImmunoResearch.
Receive alerts for 300+ data fields across thousands of companies